Denise W. Metry, MD
Baylor College of Medicine
|University of Texas Medical School at Houston||fellowship||Pediatric Dermatology||2000|
|University of Texas Medical School at Houston||residency||Dermatology||1999|
|St. Joseph Hospital Program||internship||Transitional||1996|
|University of Texas Medical School at Houston||medical school||Doctor of Medicine||1995|
Dr. Denise Metry has a special interest in the diagnosis and treatment of children with vascular birthmarks, particularly infantile hemangiomas, port-wine birthmarks, and other rare vascular birthmarks of the skin. She is dedicated to providing compassionate care for her patients and their families.
She is a founding and active member of the Hemangioma Investigator Group, an international physician working group established in 2000 to promote hemangioma research and education. She is the physician leader for the Sturge-Weber syndrome Clinical Care Network at Texas Children's Hospital, and the dermatology leader for the Vascular Birthmarks Clinic at Texas Children’s. She has authored well over 100 manuscripts and book chapters dedicated to furthering our understanding of vascular birthmarks, and she mentors, teaches and lectures locally, nationally and internationally.
Dr. Metry has longstanding expertise in the treatment of vascular birthmarks with over 20 years of experience. She offers a variety of medical treatments for infantile hemangiomas, including topical timolol and oral propranolol. She also has extensive laser experience and offers pulsed-dye laser for port-wine birthmarks, as well as alternative lasers for other types of vascular birthmarks. Lastly, she is involved in pharmaceutical research looking at novel, topical targeted gene therapies for vascular birthmarks.
Dr. Metry hosted the first PHACE syndrome research and family meeting at Texas Children's in 2008, from which diagnostic criteria for the syndrome were established. She is dedicated to vascular birthmark patient advocacy efforts in Houston, and recently has extended her passion to international mission work, having traveled to underserved parts of Asia and Africa to provide vascular birthmark education.
|Hemangioma Investigator Group (HIG)||Founding Member|
|International Society for the Study of Vascular Anomalies (ISSVA)||Member|
|National Organization for Vascular Anomalies (NOVA) & Vascular Birthmark Foundation (VBF)||Physician-Patient Liason for PHACE Syndrome|
|Pediatric Dermatology Journal||Associate Editor|
|Society of Pediatric Dermatology (SPD)||Executive Board Member and Vice Chair, Communications|
Metry D, Frieden IJ, Hess C, et al. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatric Dermatology 2013 Jan-Feb;30(1):71-89.
View all publications on VIICTR
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.